Separate chiropractic marketing tasks from HIPAA decisions that need formal review

Do not begin with the assumption that every chiropractic practice has identical HIPAA status. The HIPAA Privacy Rule applies to health care providers that meet the covered-entity definition, including providers that conduct certain covered health care transactions electronically. A practice should confirm its status and the specific transaction or business relationship before using a marketing checklist as a legal conclusion.

Protected Health Information (PHI) is individually identifiable health information held or transmitted by a covered entity or business associate in a context governed by HIPAA. In chiropractic marketing, review whether the information at issue includes:

• A patient's identity connected with information about health care, treatment, payment, or the patient relationship
• Images or video that identify or reasonably can identify an individual in connection with health care
• Health details included in a testimonial, case description, appointment request, or intake workflow
• Website or app data that, in context, relates an identifiable person to past, present, or future health, health care, or payment for health care

HIPAA does not ban general marketing or educational publishing. A practice can create service information, general educational content, office information, and community communications without using patient PHI. The compliance analysis changes when the marketing activity uses or discloses PHI, involves a business associate, or combines health-related information with identifiers.

Boundary: This content cannot guarantee compliance and is not legal or medical advice. Responsible legal, medical, privacy, security, regulatory, and state licensing reviewers remain required for decisions that fall within their expertise.

The practical question is therefore not simply "can we market?" It is "what information is involved, who receives it, why is it being used or disclosed, what rule permits that use, and what safeguards or authorization are required?" That sequence gives the SEO, website, and compliance teams a decision record they can actually review.

For a HIPAA covered entity, uses or disclosures of PHI for marketing generally require the individual's written authorization unless an exception applies. A testimonial containing identifiable patient information should therefore be reviewed as a marketing use of PHI rather than assumed to be covered by ordinary treatment consent or the Notice of Privacy Practices. A valid authorization has required elements under 45 CFR 164.508, so the practice should use a form reviewed for the intended disclosure.

• Describe the information the practice proposes to use or disclose with enough specificity for the individual to understand it
• Identify who may make the disclosure and who may receive the information or the category of recipients
• State the purpose of the use or disclosure when required
• Include an expiration date or qualifying expiration event
• Explain the applicable right to revoke the authorization
• Include the other statements, signature, and conditions required for a valid authorization

Before/after adjustment imagery needs a fact-specific review. An image can be PHI when it is individually identifiable health information maintained or transmitted by a regulated entity, but the legal analysis should not assume that every image has identical status merely because it depicts a body or treatment context. Review faces, tattoos, metadata, captions, surrounding text, account information, and other identifiers together with the purpose of publication.

Keep the authorization decision separate from clinical consent. The important issue is whether the individual's decision to authorize marketing is voluntary under the applicable rule and whether treatment, payment, enrollment, or benefits are being conditioned in a way the authorization rules do not permit. Do not use a selective outreach process that pressures patients or implies that favorable feedback affects care.

For video testimonials, the same core analysis applies to identifiable PHI used for marketing. The practice should also explain where the footage is intended to appear, how long the authorization lasts, and the practical limits of controlling copies after public publication. Legal review should determine the authorization language rather than relying on a generic social-media release.

Meta Pixel, Google Analytics, and other tracking technologies require a data-flow review rather than a blanket rule that they are always permitted or always prohibited. For HIPAA regulated entities, the key question is whether a tracking technology receives PHI and, if so, whether the use or disclosure is permitted and the vendor relationship is structured as required.

Current HHS guidance distinguishes among authenticated pages, unauthenticated pages, the information available to the technology, and the context of the user's interaction. A visit to a public condition page is not automatically enough by itself to establish PHI in every circumstance. Google Analytics 4 or another technology can still create risk when identifiers, appointment data, form information, portal data, or other context turns the transmitted information into PHI.

High-risk scenarios for chiropractic websites:

• Tracking technologies on authenticated patient portal pages where health or appointment information is available
• Remarketing or audience creation based on data that identifies a patient or relates an identifiable person to health care
• Form-tracking technologies that receive intake, symptom, appointment, or other PHI
• Conversion events that transmit appointment confirmation or patient-specific information to a third party

HHS has issued tracking-technology guidance, so do not rely on the older assumption that the Office for Civil Rights has provided no guidance. For each technology, document the exact fields, URLs, parameters, identifiers, events, cookies, and server requests transmitted; determine whether PHI is involved; then review the legal basis, business associate status, contract terms, configuration, and security safeguards.

Server-side tracking or privacy-focused analytics can change what data is sent and who receives it, but neither approach is automatically HIPAA compliant. The practice still needs a documented architecture review that matches the actual implementation.

Online intake and scheduling can create, receive, maintain, or transmit electronic PHI. The practice should inventory the full data path, including the browser, form provider, hosting environment, integrations, email notifications, practice management system, analytics scripts, backups, and staff access.

Implementation requirements: The source previously specified HTTPS with TLS 1.2 or higher. Treat that version reference as an older technical baseline to reconcile with current HHS and security guidance rather than as the complete HIPAA Security Rule. The Security Rule is technology-neutral and requires regulated entities to evaluate appropriate safeguards, including transmission security and encryption decisions, through the applicable risk analysis and implementation requirements.

Business Associate Agreements: A vendor that creates, receives, maintains, or transmits PHI on behalf of a covered entity can be a business associate, in which case the HIPAA Rules generally require an appropriate business associate contract or arrangement. Do not assume that every named form builder is automatically suitable for PHI or that every vendor requires a BAA in every use case. Review the actual service, data access, configuration, contract, and vendor role before transmitting patient information.

A scheduling workflow can involve PHI when it connects identifiable information with health care or appointment information in a context governed by HIPAA. The practice should determine what the scheduling vendor receives, whether the vendor is a business associate, what agreement is in place, and how electronic PHI is protected.

Common compliance gaps to investigate:

• Contact or intake forms collecting health information without a documented vendor, transmission, storage, and access review
• Chat or messaging tools that retain health-related conversations without the practice understanding where the records are stored or who can access them
• Scheduling or integration tools selected for convenience without checking whether their terms and data handling support the practice's HIPAA obligations

Purpose-built health care software can simplify some contractual and technical work, but no product label or vendor marketing claim guarantees compliance. The practice remains responsible for evaluating how the tool is configured and used within its own risk-management program.

Public reviews require a different communication standard from private patient conversations. A reviewer can disclose information about their own experience, but that does not automatically authorize the practice to disclose additional PHI in a public response.

The operating rule: Do not use a public response to confirm a treatment relationship, discuss a diagnosis, describe care, correct clinical details, or reveal appointment information unless the practice's qualified reviewer has identified a lawful basis for the disclosure. A privacy-protective policy can avoid confirming whether the reviewer is or was a patient.

If someone writes "Dr. Smith helped my lower back pain," the practice can use a general response that acknowledges feedback without discussing treatment. Examples include:

• "Thank you for taking the time to share your feedback."
• "We appreciate you reaching out. Please contact our office directly at [phone] so we can discuss your concerns."
• "Patient satisfaction is important to our practice. We'd welcome the opportunity to speak with you directly."

Negative reviews can create pressure to rebut details publicly. Before responding, preserve the review, route the issue to the responsible privacy or compliance owner, and decide whether a general response, private follow-up, platform report, or no response is appropriate. Do not sacrifice patient privacy to win a public argument.

For review solicitation, use a consistent policy that asks eligible patients for honest feedback without incentives, discouraging negative feedback, or selecting only satisfied patients. Avoid review gating and avoid selecting recipients based on protected health information or treatment outcomes unless qualified review establishes a lawful basis for that marketing use.

HIPAA is only one part of a chiropractic marketing review. State privacy law, state chiropractic board rules, professional scope-of-practice requirements, consumer-protection law, testimonial rules, and other federal requirements can apply independently. Because requirements vary and can change, the practice should verify current rules in every jurisdiction where the advertising is directed or the provider is regulated.

Issues commonly requiring state-level review include:

• Whether advertising claims describe conditions or services within the chiropractor's lawful scope of practice
• Whether testimonial advertising requires disclosures or other qualifying language
• Whether before/after imagery could imply a clinical result that needs substantiation or additional disclosure
• Whether terms such as "specialist" or "expert" are restricted or tied to recognized credentials
• Whether sponsorships, endorsements, or advertising relationships require disclosure

Do not assume that a disclaimer cures an unsupported health claim or that proper HIPAA authorization makes an otherwise misleading advertisement lawful. The exact wording, evidence, context, and state rule determine what is required.

FTC law can also apply to health and testimonial advertising. A testimonial that communicates an objective result may require substantiation appropriate to the claim, and disclosures must be evaluated in context. Do not rely on a stock disclaimer to convert an unsubstantiated clinical outcome into a compliant claim.

The practical review spans three separate regulatory areas described in the source: HIPAA where applicable, state professional rules, and FTC or other consumer-protection requirements. The practice should document which reviewer owns each issue and keep the final approved marketing language with the underlying authorization, substantiation, and vendor records.